Gary's new website

Thursday, February 24, 2011

Atypical leg fractures associated with Bisphosphonate use

"An increasing number of case reports describe women who develop fractures involving the subtrochanteric or shaft region of the femur in the setting of long-term bisphosphonate therapy, generally after minimal trauma. Fractures at these sites are often described as atypical because of their location and characteristic radiographic appearance."

Full article here.
If your doctor has prescribed "bone-sparing drugs" of the bisphosphonate class, think twice - better still - get out of there as quickly as you can and never go back!

I have written over 40 articles articles about these drugs.  There are at least 900 law suits in progress right now. Despite the growing evidence that these drugs are associated with enormous harm, medical practitioners world-wide, continue to prescribe these with gay abandon.

If you feel you have suffered harm from medication prescribed by a medical practitioner, my recommendation is that you file an official complaint with the Health and Disability Commissioner.  If in New Zealand, you may be eligible for cover of your health care costs and loss of income through a claim with ACC.

About this website
The advice in these articles is given freely without promise or obligation.  Its all about giving you and your family the tools and information to take control of your health and fitness.  Please give me your support by subscribing to my free email updates. Please shop at my Online Store. Please encourage your family and friends to do the same. While we may not always be able to compete with the big operators on price, we aim to more than compensate through personal service!
Your email address:

Powered by FeedBlitz
Do you have a question?  Email Gary: Include any relevant background information to your question.  Please be patient and be aware that I may not be able to answer every inquiry in detail, depending on workloads (My paying clients take precedence!). I will either reply by email or, most likely, by way of an article (Personal identifying details will be removed before publication).

No comments: